Miller Deborah Ann 4
Research Summary
AI-generated summary
Nuvalent (NUVL) CLO Deborah Miller Exercises Options, Sells Shares
What Happened
Deborah Ann Miller, Chief Legal Officer of Nuvalent, exercised stock options to acquire 15,000 shares (700 on Jan 21; 14,300 on Jan 22) at a strike price of $27.85, paying about $417,750 in aggregate. She then sold the same 15,000 shares in open-market transactions for weighted-average prices of $109.84–$110.16, generating gross proceeds of approximately $1,652,176. The filings also record derivative conversion entries at $0.00 reflecting the option-to-share conversion associated with the exercises.
Key Details
- Dates: Jan 21, 2026 (700 shares) and Jan 22, 2026 (14,300 shares).
- Exercise cost: 15,000 shares × $27.85 = $417,750 total (700 → $19,495; 14,300 → $398,255).
- Sales proceeds: 700 shares @ weighted avg $109.84 = $76,888; 14,300 shares @ weighted avg $110.16 = $1,575,288; total ≈ $1,652,176. Net proceeds before fees/taxes ≈ $1,234,426.
- Sales were reported with weighted-average prices; reported price ranges: $109.80–$109.90 (smaller lot) and $109.80–$110.75 (larger lot). The filer offers to provide breakdowns by price on request (F2, F3).
- Transactions were executed pursuant to a Rule 10b5-1 trading plan adopted Nov 18, 2024 (F1).
- Vesting note: underlying option shares vest monthly over four years beginning Jan 6, 2023 (F4).
- The Form 4 was filed on Jan 23, 2026 for trades on Jan 21–22; no late filing is indicated.
- Shares owned after the transactions are not specified in the provided filing excerpt.
Context
This was an option exercise followed by immediate open-market sales of the same shares (a sell-to-cover/cashless-style outcome). Such transactions commonly reflect routine option exercise and planned selling under a pre-established 10b5-1 plan; they are factual disclosures of insider activity and do not by themselves indicate the insider’s outlook on the company.